Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
US Army
Teva
Daiichi Sankyo
UBS
Fish and Richardson
Boehringer Ingelheim
QuintilesIMS

Generated: February 17, 2019

DrugPatentWatch Database Preview

Alpharma Us Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.



Summary for Alpharma Us Pharms
US Patents:0
Tradenames:43
Ingredients:40
NDAs:61

Drugs and US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms ERYTHROMYCIN erythromycin SOLUTION;TOPICAL 062328-001 Apr 19, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms MYKINAC nystatin OINTMENT;TOPICAL 062731-001 Sep 22, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride SYRUP;ORAL 070497-001 Apr 25, 1989 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride CONCENTRATE;ORAL 087766-001 Apr 26, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 087154-001 Sep 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062200-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-002 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-004 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-006 Approved Prior to Jan 1, 1982 4,620,974 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
Medtronic
Deloitte
Chubb
AstraZeneca
Johnson and Johnson
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.